My PCR
Create Account
Logo PCR

22 May 2019

Tricuspid / Pulmonary valveMitral valve replacement and repair

Journey toward a tailored transcatheter therapy selection part I: from mitral to tricuspid repair

Sponsored by Abbott

Chairpersons: F. Maisano, S. Windecker
Panellists: P. Guerin, G. Nickenig, G. Stone, R. S. von Bardeleben
SHOW MORE

Summary

Find out more about how new clinical evidence (MitraFR, COAPT) will shape the future of mitral transcatheter interventions.

Learning Objectives

  • To learn how will new clinical evidence (MitraFR, COAPT) shape the future of mitral transcatheter interventions
  • To learn how will product innovation (Mitraclip NTR / XTR) drive improvement in procedural and clinical outcomes (EXPAND)
  • To learn how will transcatheter therapy contribute to the treatment of tricuspid regurgitation
Related Content
Mitral interventions: translating the new guidelines into practice PCR Mitral Focus Group: advancing mitral valve care Share your work at PCR-CIT China Chengdu Valves 2025
Recommended for you
Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines Join #PCRLV - Register now! PCR Gulf Valves: Registrations are open!